Advertisement

Topics

Isotopen Technologien München Company Profile

03:52 EST 10th December 2018 | BioPortfolio


News Articles [137 Associated News Articles listed on BioPortfolio]

ITM Announces Appointment of Philip E. Harris as New Chief Medical Officer

ITM Isotopen Technologien München AG (ITM), a specialized radiopharmaceutical company, today announced the appointment of Philip E. Harris, BSc MB BCh PhD FRCP FRCB, to the posit...

Parsons bringt Schutzlösung für kritische Infrastruktur auf den Markt

Domain6 ™ integriert bewährte Technologien für Cybersecurity und physischen Schutz PASADENA, Kalifornien, 11. August 2018 /PRNewswire/ -- Parsons hat heute ein integriertes Portfolio von Technolog...

ITM: Marketing Authorization for TOCscan® (68Ga-Edotreotide) in Germany, Austria and France

ITM receives marketing authorization for a ready-to-use radiopharmaceutical in 3 European countries TOCscan® will be the companion diagnostic in ITM´s theranosti...

ITM and Merck KGaA Sign Research Evaluation and Option Agreement to Develop Folate Receptor Targeted Radionuclide Therapy

The companies to combine their technologies to develop novel theranostic radiopharmaceuticals Merck KGaA to supply folate derivatives for the preparation of folate...

Amgen Foundation und TU München bringen Biotechnologie-Unterricht an die Schulen

München (ots) - - Querverweis: Bildmaterial wird über obs versandt und ist abrufbar unter http://www.presseportal.de/bilder -Amgen Biotech Experience: "Wertvoller Baustein im Rahmen der MINT- Förde...

How do muscles know what time it is?

(Helmholtz Zentrum München - German Research Center for Environmental Health) How do muscle cells prepare for the particular metabolic challenges of the day? Scientists at Helmholtz Zentrum München ...

SIMCom hat glänzenden Auftritt auf Electronica 2018 in München (Deutschland)

MÜNCHEN, 16. November 2018 /PRNewswire/ -- SIMCom, eine hundertprozentige Tochtergesellschaft von Sunsea AIoT (SZSE-Aktienkürzel: 002313), ist der weltweit führende Anbieter von IoT-Modulen und ste...

Endocyte and ITM Announce Long-Term Supply Agreement for No-Carrier-Added Lutetium-177

Strategic Partnership supports Commercialization beyond ongoing Phase 3 VISION Trial of 177Lu-PSMA-617 Endocyte, Inc. (Nasdaq:ECYT), and ITM Isotopen Technologien München AG ...

Drugs and Medications [0 Results]

None

PubMed Articles [8 Associated PubMed Articles listed on BioPortfolio]

Enhancement of Goos-Hänchen shift due to a Rydberg state.

This paper hints at the Goos-Hänchen shift properties of a cavity containing an ensemble of atoms using a four-level atomic system involving a Rydberg state. By means of the stationary phase theory a...

Direct measurement of the composite Goos-Hänchen shift of an optical beam.

We experimentally study the Goos-Hänchen shift of a focused Gaussian optical beam in the critical region of incidence. We directly measure the beam's shift evaluated from the displacement of the loca...

Goos-Hänchen and Imbert-Fedorov shifts of higher-order Laguerre-Gaussian beams reflected from a dielectric slab.

We consider reflection of the Laguerre-Gaussian light beams by a dielectric slab. In view of the unified operator approach, the higher-order Laguerre-Gaussian beams represent a parametric family with ...

Observation of a Goos-Hänchen-like Phase Shift for Magnetostatic Spin Waves.

In optics, a light beam experiences a spatial shift in the beam plane upon total internal reflection. This shift is usually referred to as the Goos-Hänchen shift. When dealing with plane waves, it ma...

Large area silver-stibnite nanoporous plasmonic films for label-free biosensing.

The development of various plasmonic nanoporous materials have attracted much interest in different areas of research including bioengineering and biosensing because of their large surface area and ve...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Resection in Pancreatic Cancer With Minimal Metastatic Disease or Venous Infiltration Trial at Technische Universität München

PaMeViTUM is a mono-centric prospective randomized controlled trial that compares different operating procedures in patients with pancreatic cancer and minimal metastatic disease or venous...

Companies [13 Associated Companies listed on BioPortfolio]

Isotopen Technologien München

BEBIG Isotopen- und Medizintechnik GmbH

since March 2004 MCP Medical International is a part of BEBIG Isotopen- und Medizintechnik GmbH, Berlin. BEBIG is an international developer and producer of radioactive sources and devices for medical...

Cephalon GmbH

Für die Betreuung der Märkte in Deutschland, Österreich und der Schweiz wurde 1997 in München die Cephalon GmbH gegründet. Im Jahr 2002 erfolgte der Umzug nach Martinsried bei München, einem der...

Essex pharma GmbH

Nil

IRC Norddeutschland

Das EU-Verbindungsbüro für Forschung und Technologie Nordeutschland deckt durch sieben erfahrene Partner den gesamten nord- und nordostdeutschen Raum ab. Je zwei Partner haben Ihren Sitz in Berlin u...

More Information about "Isotopen Technologien München" on BioPortfolio

We have published hundreds of Isotopen Technologien München news stories on BioPortfolio along with dozens of Isotopen Technologien München Clinical Trials and PubMed Articles about Isotopen Technologien München for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Isotopen Technologien München Companies in our database. You can also find out about relevant Isotopen Technologien München Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record